Venus Medtech (Hangzhou) Inc. VMTHF
Set alert
At close · Oct 29
- YTD
- -50.65%
- 1 year
- -57.46%
- Open
- 0.4219
- Prev close
- 0.1323
- Mkt cap
- 57.93M
- Vol
- 1.00K
- Avg vol
- 1
- EPS
- -0.15
- P/E
- 0.00
More statistics
- Low
- 0.4219
- High
- 0.4219
News
1 year ago prnewswire.com
Venus Medtech Reports 2024 Annual Results: Profitability Surges with Robust Global Expansion and Innovations
HONG KONG, April 21, 2025 /PRNewswire/ -- Venus MedTech (Hangzhou) Inc. (Stock Code: 2500.HK, hereinafter referred to as "Venus Medtech" or the "Company"), a global leader in structural heart…
2 years ago prnewswire.com
Venus Medtech Venus-Vitae Completes First Two Implantations in SMART-ALIGN Pivotal Clinical Study
HANGZHOU, China , Sept. 5, 2024 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (Venus Medtech, 02500.HK), a leading provider of integrated solutions for transcatheter structural heart valvular…
2 years ago prnewswire.com
Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S.
HANGZHOU, China , June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today…
2 years ago prnewswire.com
Venus Medtech VenusP-Valve transcatheter pulmonic valve replacement system granted Health Canada approval
HANGZHOU, China , Feb. 5, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today…